Katy Webb Email & Phone Number

Cheshire, England, United Kingdom

Manchester, United Kingdom

• Responsible and accountable for the development of in-vitro companion diagnostic products, ensuring scientific integrity in accordance with company SOPs and external regulations (FDA EMEA).• Leading a multidisciplinary, global team to deliver product on time, whilst ensuring that the customer, product and regulatory requirements are fulfilled.• Communicating progress, problems and solutions to internal and external stakeholders.• Initiated knowledge share forum to drive better design practices resulting in a higher performing department.• Knowledge of documentation for FDA submissions and have drafted and reviewed sections of modules for submission to the regulatory authorities.• Managing complex interactions with pharmaceutical partners and clinical trial sites, through clear communication and negotiation to drive the success of the project. • Streamlining documentation procedures in early development phases of projects and coaching a team of approximately 140 scientists in feasibility planning and documentation. • Coaching, mentoring and developing more junior members of staff.

Manchester, United Kingdom

• Line managing a group of Scientists and Technicians.• Designing, planning and leading studies to meet product requirements and deadlines.• Liaising with multiple functions to communicate results, progress and potential problems.

Manchester, United Kingdom

Leading studies during development of companion diagnostic projectsTransfer of knowledge and skills Author protocols and reports

Worked on a Wellcome Trust funded project to develop a point of care PCR test to identify S. equi infectionWorked in collaboration with Atlas GeneticsDeveloped an new internal DNA extraction control for our laboratory diagnostic qPCR test for S. equi

Newmarket

Sequence typed over 200 S. equi isolates and determined the phylogenetic relationship using MEGA4Generated and purified over 70 GST-fusion proteins of SeMDeveloped high throughput ELISAs to determine the functional and immunological consequences of SeM variation

Newmarket

Developed a multilocus sequence typing (MLST) scheme for the opportunistic pathogen S. zooepidemicus Applied this to 273 isolates from a diverse range of infections to determine genetic relationships within the species Used phylogenetic analysis software including Start2 and eBURST to analyse the MLST data

Phd, Molecular Biology

Bsc, Microbiology